BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Guo W, Li N, Shi J, Zhang C, Lau WY, Wu M, Cheng S. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study. Br J Cancer. 2014;110:1811-1819. [PMID: 24569461 DOI: 10.1038/bjc.2014.102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Waidely E, Al-youbi AO, Bashammakh AS, El-shahawi MS, Leblanc RM. Alpha- l -Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma. Anal Chem 2017;89:9459-66. [DOI: 10.1021/acs.analchem.7b02284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Nandakumar M, Hsu Y, Lin JC, Lo C, Lo L, Lin C. Detection of Human α- L -Fucosidases by a Quinone Methide-Generating Probe: Enhanced Activities in Response to Helicobacter pylori Infection. ChemBioChem 2015;16:1555-9. [DOI: 10.1002/cbic.201500178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
3 Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 2016; 22(1): 232-252 [PMID: 26755873 DOI: 10.3748/wjg.v22.i1.232] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
4 Cheng X, Huang Y, Li D, Yuan C, Li Z, Sun L, Jiang H, Ma J. A sensitive polymer dots fluorescent sensor for determination of α-L-fucosidase activity in human serum. Sensors and Actuators B: Chemical 2019;288:38-43. [DOI: 10.1016/j.snb.2019.02.076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
5 Liang EY, Li GH, Wang WG, Qiu XM, Ke PF, He M, Huang XZ. Clinical relevance of serum α-l-fucosidase activity in the SARS-CoV-2 infection. Clin Chim Acta 2021;519:26-31. [PMID: 33826953 DOI: 10.1016/j.cca.2021.03.031] [Reference Citation Analysis]
6 Chojnowska S, Ptaszyńska-Sarosiek I, Kępka A, Szajda SD, Waszkiewicz N, Zwierz K. Optimization of the method for α-l-fucosidase, β-d-galactosidase and β-d-glucuronidase determination in serum from hemolyzed blood. Adv Med Sci 2018;63:306-11. [PMID: 29885630 DOI: 10.1016/j.advms.2018.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K, Chai ZT, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis. Ann Surg Oncol 2019;26:1465-73. [PMID: 30767178 DOI: 10.1245/s10434-019-07223-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 Li T, Li M, Hou L, Guo Y, Wang L, Sun G, Chen L. Identification and characterization of a core fucosidase from the bacterium Elizabethkingia meningoseptica. J Biol Chem 2018;293:1243-58. [PMID: 29196602 DOI: 10.1074/jbc.M117.804252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
9 Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S. Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine.J Hepatocell Carcinoma. 2019;6:151-166. [PMID: 31696097 DOI: 10.2147/JHC.S224849] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Obeidat M, Ding X, Fishbane N, Hollander Z, Ng RT, McManus B, Tebbutt SJ, Miller BE, Rennard S, Paré PD, Sin DD. The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease. Nicotine Tob Res 2016;18:1903-9. [PMID: 27154971 DOI: 10.1093/ntr/ntw129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
11 You J, Lin S, Jiang T. Origins and Evolution of the α-L-Fucosidases: From Bacteria to Metazoans. Front Microbiol 2019;10:1756. [PMID: 31507539 DOI: 10.3389/fmicb.2019.01756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wang M, Wang L, Wu S, Zhou D, Wang X. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. Int J Genomics 2019;2019:3518378. [PMID: 31886163 DOI: 10.1155/2019/3518378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yu XY, Lin SC, Zhang MQ, Guo XT, Ma K, Wang LX, Huang WT, Wang Z, Yu X, Wang CG, Zhang LJ, Yu ZT. Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(2): 498-510 [DOI: 10.4251/wjgo.v14.i2.498] [Reference Citation Analysis]
14 Yu X, Zhang R, Yang T, Zhang M, Xi K, Lin Y, Wen Y, Wang G, Huang Z, Zhang X, Zhang L. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. J Thorac Dis 2019;11:3980-90. [PMID: 31656672 DOI: 10.21037/jtd.2019.08.92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Berretta M, Cavaliere C, Alessandrini L, Stanzione B, Facchini G, Balestreri L, Perin T, Canzonieri V. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 2017;8:14192-14220. [PMID: 28077782 DOI: 10.18632/oncotarget.13929] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
16 Mintz K, Waidely E, Zhou Y, Peng Z, Al-youbi AO, Bashammakh AS, El-shahawi MS, Leblanc RM. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidase. Analytica Chimica Acta 2018;1041:114-21. [DOI: 10.1016/j.aca.2018.08.055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
17 Deng Y, Zhao Y, Fan W, Peng J, Luo X, Mo Y, Xiao B, Zhang L, Pan Z. Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection. J Cancer 2019;10:5049-56. [PMID: 31602256 DOI: 10.7150/jca.31539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J. Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma. Biologics 2016;10:139-48. [PMID: 27703327 DOI: 10.2147/BTT.S87402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Chauhan R, Lahiri N. Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer. 2016;8:37-55. [PMID: 27398029 DOI: 10.4137/bic.s34413] [Cited by in Crossref: 26] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
20 Shuang Z, Mao Y, Lin G, Wang J, Huang X, Chen J, Duan F, Li S. Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity. Biomed Res Int 2018;2018:8182575. [PMID: 29682557 DOI: 10.1155/2018/8182575] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Sun JJ, Wang K, Zhang CZ, Guo WX, Shi J, Cong WM, Wu MC, Lau WY, Cheng SQ. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion. Ann Surg Oncol. 2016;23:1344-1351. [PMID: 26714945 DOI: 10.1245/s10434-015-5008-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
22 Zayed Mohamed N, Aly HF, Moneim El-Mezayen HA, El-Salamony HE. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicol Rep 2019;6:875-88. [PMID: 31516840 DOI: 10.1016/j.toxrep.2019.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Xi L, Yang C. Evaluation of alpha-l-fucosidase for the diagnosis of hepatocellular carcinoma based on meta-analysis. Journal of Laboratory Medicine 2020;44:183-9. [DOI: 10.1515/labmed-2019-0152] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Liu T, Liu R, Zhu L, Zou X, Guan H, Xu Z. Development of a UHPLC-MS method for inhibitor screening against α-L-1,3-fucosidase. Anal Bioanal Chem 2019;411:1467-77. [PMID: 30706074 DOI: 10.1007/s00216-019-01575-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Liu D, Luo Y, Chen L, Chen L, Zuo D, Li Y, Zhang X, Wu J, Xi Q, Li G, Qi L, Yue X, Zhang X, Sun Z, Zhang N, Song T, Lu W, Guo H. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study. Cancer Biol Med 2021;18:256-70. [PMID: 33628599 DOI: 10.20892/j.issn.2095-3941.2020.0207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]